The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Clinical Cancer Research|2020Cited by 86
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate CancerEstefanía Labanca, Nora M. Navone, Jun Yang et al.|European Urology Oncology|2021Cited by 28
Bempegaldesleukin (<scp>BEMPEG</scp>; <scp>NKTR</scp>‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcomaMarlene Hennessy, Nancy Gordon, Andrew Wahba et al.|International Journal of Cancer|2020Cited by 20
Visualization and Quantification of Intraperitoneal Tumors by In Vivo Computed Tomography Using Negative Contrast Enhancement Strategy in a Mouse Model of Ovarian CancerMurtuza Rampurwala, Vikas Kundra, Murali K. Ravoori et al.|Translational Oncology|2009Cited by 7
Table S5 from The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy DevelopmentNallasivam Palanisamy, Nora M. Navone, Jun Yang et al.|Unknown|2023Cited by 0